hVIVO plc (formerly Open Orphan plc)
Company Profile
hVIVO plc (ticker: HVO) (formerly Open Orphan plc) is a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials. The Group provides end-to-end early clinical development services to its large, established and growing repeat client base, which includes four of the top 10 largest global biopharma companies.
Investor Access
2023 Annual General Meeting
(please check the link for more information: https://hvivo.com/company-documents/
Event | Date |
Year End | 31 December |
Half Year End | 30 June |
Preliminary Results* | April |
Interim Results* | September |
AGM* | May |
* Months based on previous announcements of this kind